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Abstract
Purpose: The purpose of this study is to analyze and compare the dosimetric parameters of three dimensional conformal radio-
therapy (3DCRT) and intensity modulated radiotherapy (IMRT) in selected non-small cell lung cancer (NSCLC) cases. Methods:
Ten patients with inoperable NSCLC were selected for this study. The 3DCRT and IMRT plans were generated for all patients
following Radiation Therapy Oncology Group (RTOG) guidelines. Generated plans were then compared on the basis of planning
target volume (PTV) coverage, dose delivered to organs at risk, homogeneity index (HI), and conformity index (CI) for the pre-
scribed dose (PD) of 50 Gy in 25 fractions. Results: The mean D95 and D99 (dose to the 95% and 99% volume) for the PTV were
found better in the 3DCRT plans compared to the ones in the IMRT plans. On an average, the volume receiving 20 Gy (V20) of
contralateral lung was 2.91% and 3.03% in the 3DCRT and IMRT plans, respectively. The Dmean of contralateral lung was 3.17
Gy (3DCRT) versus 4.2 Gy (IMRT), whereas the Dmean of ipsilateral lung was 12.69 Gy (3DCRT) and 13.82 Gy (IMRT). The V20
of ipsilateral lung was found to be slightly lower in the 3DCRT (25.67%) when compared to the IMRT (30.50%). The dose to
the heart was comparable in the 3DCRT and IMRT plans (mean dose: 4.42 Gy versus 4.48 Gy; D33: 3.77 Gy versus and 4.02 Gy).
For the spinal cord, the Dmaxwas found to be lower in the 3DCRT plans (18.40 Gy) when compared to the IMRT plans (25.49
Gy). The HI was 1.08 versus 1.41 in the 3DCRT and IMRT plans, respectively. The CI was identical (1.67) in both sets of plans.
Conclusion: Based on the results of this study, the PTV coverage was found to be slightly better in the 3DCRT plans when
compared to the one in the IMRT plans. On average, the dose to the organs at risk were found to be comparable.
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Introduction
Radiotherapy is an integral part of non-small cell lung cancer
(NSCLC) management and using this therapy the main aim is
to treat patient with less complications. The modern radio-
therapy has evolved from hand-drawn delineation of target
on patient body to three dimensional reconstructions of
computed tomography (CT) images with the help of advance
computer algorithm. In the early 1990s, three dimensional
conformal radiation therapy (3DCRT) using CT images was
standard method to deliver radiation using a set of intersect-
ing beams of two dimensional shapes, from which three di-
mensional high dose region of approximately tumor shape
can be achieved to treat the cancer.
The more advance technology intensity modulated radiation
therapy (IMRT) was innovated in the late 1990s. In IMRT,
the intensity of each beam is modified with the help of multi
leaf collimators (MLC) according to the shape of the tumor.
With this technique any tumor shaped can be acquired hav-
ing sudden dose fall outside the region of interest. The use of
IMRT technique increased over the last decade but there are
certain limitations of this technique, IMRT plans are complex
and inappropriate where intrafractional motion of the target
is large, such as in lung tumors.1
Recent developments in image guided radiotherapy (IGRT)
are leading in a new era of radiotherapy for lung tumor. IGRT
is the modern technique, which is more accurate when there
is an organ motion during treatment such as lung tumor.
IGRT involves real time imaging of target and helps to indi-
vidualize radiotherapy by accounting tumor motion. It has
got ability of high precision dose delivery and real-time
knowledge of the target volume location. IGRT has initiated
the exploration of new indications for radiotherapy.
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In case of NSCLC, 3DCRT is being used since long time but
IMRT and IGRT have been advocated always superior tech-
nique to further decrease the volume of normal tissue exposed
to high doses of radiation.2,3 Respiratory motion alters the
dose distributions actually delivered while treating patients
from those predicted by plans based on static CT scans.4Thus
the modulated dose distribution within the volume by IMRT
or 3DCRT planned on stationary CT images is matter of
concern compare to IGRT where uniform dose is delivered in
whole treatment volume using real time images of target
during treatment. Although the IGRT is more accurate tech-
nique compared to 3DCRT and IMRT, but still its use is lim-
ited due to many factors such as accessibility of technology,
financial considerations, etc. Thus, 3DCRT or IMRT is used in
most of the radiotherapy centers in the developing countries.
As lung tumor motion may cause significant degree of dose
deviation and uncertainty, the under dosing to the target
volume is likely, thus resulting adverse effects on normal
tissues in IMRT as compared to 3DCRT if any gated system is
not used for the IMRT. This study aims to evaluate the
3DCRT and IMRT planning techniques for the selected
NSCLC patients.
Methods and Materials
CT simulation
In the present study, ten inoperable patients diagnosed with
NSCLC were selected. Thermoplastic sheet (Orfit) was used
for each patient to immobilize the site of interest. Siemens
SOMATOM Definition AS scanner (Siemens Medical Sys-
tems, Germany) was utilized for the CT scan of the patients
and the CT images of 3 mm slice thickness were acquired for
each patient in supine position. The CT images were trans-
ferred to the Eclipse treatment planning system (TPS), ver-
sion 8.9 (Varian Medical Systems, Palo Alto, CA). The gross
tumor volume (GTV), clinical tumor volume (CTV), planning
target volume (PTV) and organs at risk (OARs) were deline-
ated on the CT images following the International Commis-
sion on Radiation Units and Measurements report 83 (ICRU
83).5The size of PTV varied from 163 cm3 to 241.7 cm3with a
mean value of 202.35 cm3. The 3DCRT as well as IMRT plans
for all the cases were created on the same CT data set. All the
plans were done for 50 Gy in 25 fractions (#) with 2 Gy/# and
five fractions per week.
Treatment planning
Treatment plans were executed by high energy medical linear
accelerator (LA) Clinac DMX (Varian Medical Systems, Palo
Alto, CA) having 6 and 15 MV photon energies. It is equipped
with Millennium 80 MLC having 40 pairs of leaves and leaf
width projected at isocenter is 1 cm. The 3DCRT plans were
generated by using two to five coplanar fields at desired gan-
try angles. Wedges of suitable angle were also used in some
plans to get desired dose distribution. All 3DCRT plans were
generated by using 6 MV, 15 MV or combination of both the
photon energies. By using only low energy (6 MV), it was not
possible to achieve desired dose distribution inside the PTV in
some of the 3DCRT plans, and thus the combination of low (6
MV) and high (15 MV) energy was used in such plans. Hot
spots, cold spots, and dose homogeneity were managed by
increasing and decreasing monitoring units (MU) of particu-
lar fields.
IMRT plans were generated by using coplanar fields of suita-
ble gantry angles.6 Desired PTV coverage was achieved by 6
MV only. Thus, 15 MV or combination of 6 and 15 MV was
not used. Two fields at single gantry angle were also used in
some of the plans because of a large target volume if field size
exceeded more than 14.5 cm in x-direction and it splits into
two fields automatically.7 The splitting is because of the lim-
itation that is present in MLC, where the maximum distance
between the most retracted and extended MLC cannot be
more than 14.5 cm. Dose constraints and adequate weights for
the OARs and target volumes were given to the TPS to ob-
tained optimum IMRT plans. Dose volume optimizer (DVO)
was used for plan optimization and doses were calculated by
using anisotropic analytical algorithm (AAA) with 0.25 cm
dose calculation grid size.
Plan analysis
The IMRT and 3DCRT plans were evaluated and compared
on the basis of dosimetric parameters viz., target coverage,
doses to OARs, homogeneity index (HI) and conformity in-
dex (CI). HI and CI were calculated by using following for-
mulae;8
5
95
DHI = D
where, D5 is dose to 5% volume of PTV and D95 is dose to 95%
volume of PTV.
Volume receiving 95% of Prescribed DoseCI PTV
Statistical analyses of the data sets were done to determine
the statistical difference between 3DCRT and IMRT. The
p-values were calculated by using unpaired t-test for all the
data sets.
Results
The detailed results are given in Table 1. Figure 1 shows the
dose distribution on CT image for (a) 3DCRT and (b) IMRT
done for one of the selected patients. The mean dose to 95%
(D95) and 99% (D99) of PTV was 96.50% (Standard deviation
(SD): 1.48) and 94.45% (SD: 2.02) for 3DCRT and 94.76%
(SD: 2.07) and 90.49% (SD: 4.02) for IMRT, respectively.
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TABLE 1: Dosimetric data of three dimensional conformal radiotherapy (3DCRT) and intensity modulated radiotherapy (IMRT) for ten patients
in the case of NASLC
Patient No.
PTV coverage Epsilateral lung Contralateral
lung
Heart Spinal
cord
HI CI
D95%
(%of PD)
D99%
(%of PD)
V20
(%)
Dmean
(Gy)
(V20)
(%)
Dmean
(Gy)
D33%
(Gy)
D67%
(Gy)
Dmean
(Gy)
Dmax
(Gy)
1 3DCRT 99.24 98.27 19.60 9.36 0 0.28 0.37 0.22 0.34 6.62 1.06 2.24
IMRT 96.10 94.67 27.85 13.15 0 2.85 0.97 0.47 1.01 20.22 2.90 2.90
2 3DCRT 96 94.37 38.74 17.97 1.81 4.81 6.63 1.62 8.25 34.57 1.05 1.70
IMRT 96.22 92.67 48.06 19.91 7.25 6.57 4.83 2.29 6.04 33.19 1.06 1.86
3 3DCRT 95.40 93 18.85 9.03 0 1.29 7.12 5.21 7.96 0.65 1.01 1.23
IMRT 91.6 84 9.34 6.08 0 1.33 9.11 5.06 10.14 5.15 1.15 1.04
4 3DCRT 95.12 92.05 20.71 11.58 7.87 4.81 0.91 0.54 0.94 20.75 1.09 1.55
IMRT 93.76 89.81 28.82 12.74 2.19 4.79 1.35 0.67 1.20 33.74 1.12 1.22
5 3DCRT 96.46 95.56 39.04 18.03 1.95 4.99 7.02 1.97 8.90 35.87 1.10 1.82
IMRT 97.02 93.89 49.00 20.02 8.13 7.03 5.86 2.89 7.12 34.22 1.19 1.92
6 3DCRT 95.92 94.17 38.12 17.66 1.51 4.12 6.42 1.40 8.12 34.02 1.01 1.60
IMRT 96.58 91.93 48.00 19.02 7.05 6.17 4.70 2.10 5.00 33.00 1.06 1.81
7 3DCRT 95.32 92.5 18.05 9.00 0 1.09 7.02 5.01 7.42 1.55 1.08 1.20
IMRT 91.2 83 9.04 6.00 0 1.20 9.00 5.00 9.96 5.10 1.12 1.12
8 3DCRT 98.16 94.25 23.81 13.25 8.08 5.25 1.00 0.73 1.01 23.13 1.19 1.77
IMRT 95.96 91.32 29.22 15.42 3.19 5.09 1.93 0.97 2.12 37.53 1.20 1.52
9 3DCRT 98.13 97.15 18.96 9.10 0 0.19 0.26 0.21 0.30 5.92 1.03 1.92
IMRT 95.35 93.67 26.79 12.98 0 2.12 0.87 0.40 0.99 18.94 2.1 2.0
10 3DCRT 95.24 93.17 20.79 11.96 7.90 4.89 0.92 0.56 0.99 20.82 1.10 1.58
IMRT 93.82 89.90 28.85 12.85 2.53 4.85 1.57 0.77 1.23 33.82 1.19 1.29
Me
an 3DCRT 96.50 94.45 25.67 12.69 2.91 3.17 3.77 1.78 4.42 18.40 1.08 1.67
IMRT 94.76 90.49 30.50 13.82 3.03 4.2 4.02 2.06 4.48 25.49 1.41 1.67
SD
3DCRT 1.48 2.02 9.09 3.86 3.56 2.16 3.26 1.87 3.93 13.90 0.05 0.31
IMRT 2.07 4.02 14.50 5.05 3.29 2.17 3.20 1.78 3.69 12.36 0.61 0.56
p-value 0.04* 0.01* 0.38 0.58 0.97 0.30 0.86 0.70 0.97 0.24 0.10 0.97
FIG. 1: Dose distribution on CT slices for (a) 3DCRT and (b) IMRT plan.
On an average of all the patients, volume of contralateral
lung receiving 20 Gy (V20) was 2.91% (SD: 3.56) and 3.03%
(SD: 3.29), Dmean of contralateral lung was 3.17 Gy (SD: 2.15)
and 4.2 Gy (SD: 2.17), V20 of ipsilateral lung was 25.67% (SD:
9.08) and 30.50% (SD: 14.50) and Dmean of ipsilateral lung was
12.69 Gy (SD: 3.86) and 13.82 Gy (SD: 5.04) in 3DCRT and
IMRT, respectively. D33 of heart was 3.77 Gy (SD: 3.26) and
4.02 Gy (SD: 3.20), D67 of heart was 1.78 Gy (SD: 1.87) and
2.06 Gy (SD: 1.78) and Dmean of heart was 4.42 Gy (SD: 3.93)
and 4.48 Gy (SD: 3.69) in 3DCRT and IMRT respectively.
Dmax to spinal cord was 18.40 Gy (SD: 13.90) and 25.49 Gy
(SD: 12.36) in 3DCRT and IMRT, respectively.
HI was 1.08 (SD: 0.05) and 1.409 (SD: 0.61) and CI was 1.67
(SD: 0.31) and 1.67 (SD: 0.57) in 3DCRT and IMRT respec-
tively.
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FIG.2: Comparison of dose volume histogram (DVH) for 3DCRT and IMRT plan.
Discussion
From the Table 1, it can be concluded that the D95% and D99%
of PTV in 3DCRT plans had better coverage than that in
IMRT and the p-values 0.044 and 0.012 showed the statistical
significant difference for both the techniques. The p-values
calculated for critical organs such as contractual lung for V20,
and Dmean were 0.97 and 0.302, for heart D33%, D67% and Dmean%
were 0.86, 0.70, and 0.97 and for the spinal cord Dmax% was
0.24 respectively. All the p-values for the OARs were > 0.05,
which indicates non-significant difference in the doses to the
OARs in both the techniques although the doses to the OARs
were lower in some of the 3DCRT plans while higher in other
3DCRT plans when compared to the IMRT. Figure 2 shows
the comparative dose volume histogram for the 3DCRT and
IMRT done for one of the selected case which indicates that
the PTV coverage was better in the 3DCRT than in the IMRT
as well as lower hot spot in the 3DCRT. Dose to ipsilateral
lung and contralateral lung in the 3DCRT was slightly less
than the ones in the IMRT.
Treatment planning algorithm plays a crucial role for dose
calculations though the advance algorithm based on Monte
Carlo is more accurate but it has got its own limitations. Re-
cently, a new dose calculation algorithm called Acuros XB
(AXB) has been introduced within the Eclipse TPS, and the
AXB is considered similar to Monte Carlo. A number of re-
searchers have already presented that the AXB is more accu-
rate algorithm compare to others such as AAA.9,10 Superposi-
tion-convolution based algorithms such as AAA which is
more accurate compared to pencil beam convolution (PBC)
can also be used for dose calculations. AAA has separate
modeling for primary photons, scattered photons and con-
taminant electrons for dose calculation.11,12 In this study, the
3DCRT and IMRT plans were generated using AAA since
AXB was not available in our TPS during the time of study.
However, Rana et al. 9 and Ojala et al. 10 have recommended
to use AXB instead of AAA for dose calculations when low
density media such as lung tissue is involved along the photon
beam path. The use of accurate dose calculation algorithm is
important for the lung cancer to ensure sufficient dose cov-
erage. Recently, there is a significant interest in using proton
therapy for the cancer treatment since particle therapy offers
localized dose deposition with no exist deposition. The proton
therapy can potential provide dosimetric advantages over
conventional photon therapy such as IMRT.13,14
Conclusion
Based on the results of this study, the PTV coverage was
found to be slightly better in the 3DCRT plans when com-
pared to the one in the IMRT plans. On average, the dose to
the organs at risk were found to be comparable. Since there is
a possibility of lung tumor motion during the treatment,
3DCRT, which is cost effective and requires less treatment
time, can be preferred over IMRT in some of the NSCLC cases
in this study.
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